for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. FDA gives emergency use approval to GSK-Vir COVID-19 antibody drug

May 26 (Reuters) - The U.S. Food and Drug administration on Wednesday gave an emergency use authorization to the COVID-19 antibody treatment developed by Vir Biotechnology Inc and GlaxoSmithKline. (bit.ly/3uorQZ8) (Reporting by Amruta Khandekar; Editing by Shounak Dasgupta)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up